GenapSys launches sequencer in Asia, lands new funding

By The Science Advisory Board staff writers

February 12, 2020 -- GenapSys has launched its gene sequencer in the Asia-Pacific region and garnered $75 million in financing to support its international expansion.

The firm said its gene sequencer is positioned to help researchers and public health officials across Asia better track and understand the coronavirus outbreak. The sequencer is less expensive and 100 times smaller than legacy high-throughput sequencers, and it can run off a standard power source, according to the vendor.

The international growth initiative will be supported by a $75 million financing deal from Oxford Finance, according to GenapSys. The company has already signed 25 distributorship deals worldwide with partners including Research Instruments of Singapore, Biomedical Systems of Korea, and Gene Company in Hong Kong. GenapSys said it's also interested in partnering with local health agencies and researchers.

Although it's currently focused on helping researchers and clinicians obtain access to its sequencer to combat pandemic outbreaks, the firm said the technology's benefits extend beyond infectious diseases to applications in cancer research, food science, personalized medicine, forensics, and other key scientific and medical fields.

Chinese researchers mobilize to classify 2019-nCoV
In response to a recent outbreak of the novel coronavirus (2019-CoV), scientists in China have uncovered genetic similarities with severe acute respiratory...
Institut Pasteur reveals how it sequenced the coronavirus
On January 30, the Institut Pasteur became the first European institution to sequence the novel coronavirus (2019-nCoV) since the outbreak began in December...
NGS of China coronavirus shows bat origins, intermediate host
Next-generation sequencing (NGS) of 10 genomes of novel coronavirus (2019-nCoV) from nine patients in China demonstrated that the virus is closely related...
Enrichment NGS emerges as surveillance tool for coronavirus
As the coronavirus continues to grow as a global health concern, researchers urgently seek efficient methods to predict and mitigate emerging coronavirus...

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Conferences
BioProcess International Europe
April 28 - May 1
Amsterdam, Noord-Holland Netherlands
Lab of the Future USA
May 19-20
Boston, Massachusetts United States
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
BioProcess International
September 21-24
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter